INT J LAB HEMATOL 润色咨询

International Journal of Laboratory Hematology

出版年份:2007 年文章数:1116 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:12.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=583868, encodeId=cb485838686f, content=请问接受case reports吗?<span class="quote">156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表:<br>您好,给编辑写信的邮箱能发下吗</span>, beContent=156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表: 您好,给编辑写信的邮箱能发下吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89b683177, createdName=wf031, createdTime=Sun Jan 26 00:00:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197030, encodeId=b97b119e030f8, content=偏重的研究方向:血液病分子生物学<br>经验分享:2022-02-16 su bmit 2022-02-18 编辑退回要求修改格式 2022-02-19 waiti n g ad m in..... 2022-02-23 U nder review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Thu Feb 24 22:21:33 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908358, encodeId=585c908358fb, content=请问审稿费多少呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a55434745, createdName=ms3000000661874644, createdTime=Tue Dec 15 22:52:17 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219448, encodeId=71f412194488c, content=投了一个月了还在awaiting reviewer assignment...服了太慢了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59915318778, createdName=148a3739m53暂无昵称, createdTime=Fri May 13 19:57:38 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198801, encodeId=ba7711988016e, content=请问Awaiting reviewer assignment会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Wed Mar 02 18:11:19 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552751, encodeId=ae96552e51c6, content=投出去快一礼拜了还是Awaiting Admin Processing,天天查状态,可能得等半个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3482046489, createdName=刘壮, createdTime=Mon Feb 19 16:08:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800420, encodeId=4604800420a4, content=审了一个半月+,还在awaiting reviewer scores, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6293088697, createdName=1303935745, createdTime=Mon Jun 29 21:40:07 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089551, encodeId=1d47108955100, content=评审和期刊编辑一般会询问什么问题?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089552, encodeId=145e1089552af, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586169, encodeId=6876586169dc, content=请问这个杂志接不接受case report呢?我也在找发case的杂志。<span class="quote">wf031 2020-01-26 00:00:00 发表:<br>请问接受case reports吗?</span>, beContent=wf031 2020-01-26 00:00:00 发表: 请问接受case reports吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4995310914, createdName=14888d7am37暂无昵称, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]
    2020-01-26 wf031

    请问接受case reports吗?156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表:
    您好,给编辑写信的邮箱能发下吗

    156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表: 您好,给编辑写信的邮箱能发下吗

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=583868, encodeId=cb485838686f, content=请问接受case reports吗?<span class="quote">156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表:<br>您好,给编辑写信的邮箱能发下吗</span>, beContent=156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表: 您好,给编辑写信的邮箱能发下吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89b683177, createdName=wf031, createdTime=Sun Jan 26 00:00:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197030, encodeId=b97b119e030f8, content=偏重的研究方向:血液病分子生物学<br>经验分享:2022-02-16 su bmit 2022-02-18 编辑退回要求修改格式 2022-02-19 waiti n g ad m in..... 2022-02-23 U nder review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Thu Feb 24 22:21:33 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908358, encodeId=585c908358fb, content=请问审稿费多少呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a55434745, createdName=ms3000000661874644, createdTime=Tue Dec 15 22:52:17 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219448, encodeId=71f412194488c, content=投了一个月了还在awaiting reviewer assignment...服了太慢了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59915318778, createdName=148a3739m53暂无昵称, createdTime=Fri May 13 19:57:38 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198801, encodeId=ba7711988016e, content=请问Awaiting reviewer assignment会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Wed Mar 02 18:11:19 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552751, encodeId=ae96552e51c6, content=投出去快一礼拜了还是Awaiting Admin Processing,天天查状态,可能得等半个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3482046489, createdName=刘壮, createdTime=Mon Feb 19 16:08:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800420, encodeId=4604800420a4, content=审了一个半月+,还在awaiting reviewer scores, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6293088697, createdName=1303935745, createdTime=Mon Jun 29 21:40:07 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089551, encodeId=1d47108955100, content=评审和期刊编辑一般会询问什么问题?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089552, encodeId=145e1089552af, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586169, encodeId=6876586169dc, content=请问这个杂志接不接受case report呢?我也在找发case的杂志。<span class="quote">wf031 2020-01-26 00:00:00 发表:<br>请问接受case reports吗?</span>, beContent=wf031 2020-01-26 00:00:00 发表: 请问接受case reports吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4995310914, createdName=14888d7am37暂无昵称, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]
    2022-02-24 ms4000000531946229

    偏重的研究方向:血液病分子生物学
    经验分享:2022-02-16 su bmit 2022-02-18 编辑退回要求修改格式 2022-02-19 waiti n g ad m in..... 2022-02-23 U nder review

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=583868, encodeId=cb485838686f, content=请问接受case reports吗?<span class="quote">156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表:<br>您好,给编辑写信的邮箱能发下吗</span>, beContent=156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表: 您好,给编辑写信的邮箱能发下吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89b683177, createdName=wf031, createdTime=Sun Jan 26 00:00:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197030, encodeId=b97b119e030f8, content=偏重的研究方向:血液病分子生物学<br>经验分享:2022-02-16 su bmit 2022-02-18 编辑退回要求修改格式 2022-02-19 waiti n g ad m in..... 2022-02-23 U nder review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Thu Feb 24 22:21:33 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908358, encodeId=585c908358fb, content=请问审稿费多少呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a55434745, createdName=ms3000000661874644, createdTime=Tue Dec 15 22:52:17 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219448, encodeId=71f412194488c, content=投了一个月了还在awaiting reviewer assignment...服了太慢了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59915318778, createdName=148a3739m53暂无昵称, createdTime=Fri May 13 19:57:38 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198801, encodeId=ba7711988016e, content=请问Awaiting reviewer assignment会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Wed Mar 02 18:11:19 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552751, encodeId=ae96552e51c6, content=投出去快一礼拜了还是Awaiting Admin Processing,天天查状态,可能得等半个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3482046489, createdName=刘壮, createdTime=Mon Feb 19 16:08:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800420, encodeId=4604800420a4, content=审了一个半月+,还在awaiting reviewer scores, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6293088697, createdName=1303935745, createdTime=Mon Jun 29 21:40:07 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089551, encodeId=1d47108955100, content=评审和期刊编辑一般会询问什么问题?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089552, encodeId=145e1089552af, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586169, encodeId=6876586169dc, content=请问这个杂志接不接受case report呢?我也在找发case的杂志。<span class="quote">wf031 2020-01-26 00:00:00 发表:<br>请问接受case reports吗?</span>, beContent=wf031 2020-01-26 00:00:00 发表: 请问接受case reports吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4995310914, createdName=14888d7am37暂无昵称, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]
    2020-12-15 ms3000000661874644

    请问审稿费多少呢?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=583868, encodeId=cb485838686f, content=请问接受case reports吗?<span class="quote">156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表:<br>您好,给编辑写信的邮箱能发下吗</span>, beContent=156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表: 您好,给编辑写信的邮箱能发下吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89b683177, createdName=wf031, createdTime=Sun Jan 26 00:00:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197030, encodeId=b97b119e030f8, content=偏重的研究方向:血液病分子生物学<br>经验分享:2022-02-16 su bmit 2022-02-18 编辑退回要求修改格式 2022-02-19 waiti n g ad m in..... 2022-02-23 U nder review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Thu Feb 24 22:21:33 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908358, encodeId=585c908358fb, content=请问审稿费多少呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a55434745, createdName=ms3000000661874644, createdTime=Tue Dec 15 22:52:17 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219448, encodeId=71f412194488c, content=投了一个月了还在awaiting reviewer assignment...服了太慢了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59915318778, createdName=148a3739m53暂无昵称, createdTime=Fri May 13 19:57:38 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198801, encodeId=ba7711988016e, content=请问Awaiting reviewer assignment会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Wed Mar 02 18:11:19 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552751, encodeId=ae96552e51c6, content=投出去快一礼拜了还是Awaiting Admin Processing,天天查状态,可能得等半个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3482046489, createdName=刘壮, createdTime=Mon Feb 19 16:08:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800420, encodeId=4604800420a4, content=审了一个半月+,还在awaiting reviewer scores, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6293088697, createdName=1303935745, createdTime=Mon Jun 29 21:40:07 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089551, encodeId=1d47108955100, content=评审和期刊编辑一般会询问什么问题?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089552, encodeId=145e1089552af, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586169, encodeId=6876586169dc, content=请问这个杂志接不接受case report呢?我也在找发case的杂志。<span class="quote">wf031 2020-01-26 00:00:00 发表:<br>请问接受case reports吗?</span>, beContent=wf031 2020-01-26 00:00:00 发表: 请问接受case reports吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4995310914, createdName=14888d7am37暂无昵称, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]
    2022-05-13 148a3739m53暂无昵称

    投了一个月了还在awaiting reviewer assignment...服了太慢了吧

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=583868, encodeId=cb485838686f, content=请问接受case reports吗?<span class="quote">156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表:<br>您好,给编辑写信的邮箱能发下吗</span>, beContent=156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表: 您好,给编辑写信的邮箱能发下吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89b683177, createdName=wf031, createdTime=Sun Jan 26 00:00:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197030, encodeId=b97b119e030f8, content=偏重的研究方向:血液病分子生物学<br>经验分享:2022-02-16 su bmit 2022-02-18 编辑退回要求修改格式 2022-02-19 waiti n g ad m in..... 2022-02-23 U nder review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Thu Feb 24 22:21:33 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908358, encodeId=585c908358fb, content=请问审稿费多少呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a55434745, createdName=ms3000000661874644, createdTime=Tue Dec 15 22:52:17 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219448, encodeId=71f412194488c, content=投了一个月了还在awaiting reviewer assignment...服了太慢了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59915318778, createdName=148a3739m53暂无昵称, createdTime=Fri May 13 19:57:38 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198801, encodeId=ba7711988016e, content=请问Awaiting reviewer assignment会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Wed Mar 02 18:11:19 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552751, encodeId=ae96552e51c6, content=投出去快一礼拜了还是Awaiting Admin Processing,天天查状态,可能得等半个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3482046489, createdName=刘壮, createdTime=Mon Feb 19 16:08:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800420, encodeId=4604800420a4, content=审了一个半月+,还在awaiting reviewer scores, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6293088697, createdName=1303935745, createdTime=Mon Jun 29 21:40:07 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089551, encodeId=1d47108955100, content=评审和期刊编辑一般会询问什么问题?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089552, encodeId=145e1089552af, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586169, encodeId=6876586169dc, content=请问这个杂志接不接受case report呢?我也在找发case的杂志。<span class="quote">wf031 2020-01-26 00:00:00 发表:<br>请问接受case reports吗?</span>, beContent=wf031 2020-01-26 00:00:00 发表: 请问接受case reports吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4995310914, createdName=14888d7am37暂无昵称, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]
    2022-03-02 ms4000000531946229

    请问Awaiting reviewer assignment会持续多久啊

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=583868, encodeId=cb485838686f, content=请问接受case reports吗?<span class="quote">156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表:<br>您好,给编辑写信的邮箱能发下吗</span>, beContent=156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表: 您好,给编辑写信的邮箱能发下吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89b683177, createdName=wf031, createdTime=Sun Jan 26 00:00:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197030, encodeId=b97b119e030f8, content=偏重的研究方向:血液病分子生物学<br>经验分享:2022-02-16 su bmit 2022-02-18 编辑退回要求修改格式 2022-02-19 waiti n g ad m in..... 2022-02-23 U nder review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Thu Feb 24 22:21:33 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908358, encodeId=585c908358fb, content=请问审稿费多少呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a55434745, createdName=ms3000000661874644, createdTime=Tue Dec 15 22:52:17 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219448, encodeId=71f412194488c, content=投了一个月了还在awaiting reviewer assignment...服了太慢了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59915318778, createdName=148a3739m53暂无昵称, createdTime=Fri May 13 19:57:38 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198801, encodeId=ba7711988016e, content=请问Awaiting reviewer assignment会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Wed Mar 02 18:11:19 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552751, encodeId=ae96552e51c6, content=投出去快一礼拜了还是Awaiting Admin Processing,天天查状态,可能得等半个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3482046489, createdName=刘壮, createdTime=Mon Feb 19 16:08:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800420, encodeId=4604800420a4, content=审了一个半月+,还在awaiting reviewer scores, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6293088697, createdName=1303935745, createdTime=Mon Jun 29 21:40:07 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089551, encodeId=1d47108955100, content=评审和期刊编辑一般会询问什么问题?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089552, encodeId=145e1089552af, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586169, encodeId=6876586169dc, content=请问这个杂志接不接受case report呢?我也在找发case的杂志。<span class="quote">wf031 2020-01-26 00:00:00 发表:<br>请问接受case reports吗?</span>, beContent=wf031 2020-01-26 00:00:00 发表: 请问接受case reports吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4995310914, createdName=14888d7am37暂无昵称, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]
    2018-02-19 刘壮

    投出去快一礼拜了还是Awaiting Admin Processing,天天查状态,可能得等半个月吧

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=583868, encodeId=cb485838686f, content=请问接受case reports吗?<span class="quote">156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表:<br>您好,给编辑写信的邮箱能发下吗</span>, beContent=156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表: 您好,给编辑写信的邮箱能发下吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89b683177, createdName=wf031, createdTime=Sun Jan 26 00:00:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197030, encodeId=b97b119e030f8, content=偏重的研究方向:血液病分子生物学<br>经验分享:2022-02-16 su bmit 2022-02-18 编辑退回要求修改格式 2022-02-19 waiti n g ad m in..... 2022-02-23 U nder review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Thu Feb 24 22:21:33 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908358, encodeId=585c908358fb, content=请问审稿费多少呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a55434745, createdName=ms3000000661874644, createdTime=Tue Dec 15 22:52:17 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219448, encodeId=71f412194488c, content=投了一个月了还在awaiting reviewer assignment...服了太慢了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59915318778, createdName=148a3739m53暂无昵称, createdTime=Fri May 13 19:57:38 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198801, encodeId=ba7711988016e, content=请问Awaiting reviewer assignment会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Wed Mar 02 18:11:19 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552751, encodeId=ae96552e51c6, content=投出去快一礼拜了还是Awaiting Admin Processing,天天查状态,可能得等半个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3482046489, createdName=刘壮, createdTime=Mon Feb 19 16:08:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800420, encodeId=4604800420a4, content=审了一个半月+,还在awaiting reviewer scores, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6293088697, createdName=1303935745, createdTime=Mon Jun 29 21:40:07 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089551, encodeId=1d47108955100, content=评审和期刊编辑一般会询问什么问题?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089552, encodeId=145e1089552af, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586169, encodeId=6876586169dc, content=请问这个杂志接不接受case report呢?我也在找发case的杂志。<span class="quote">wf031 2020-01-26 00:00:00 发表:<br>请问接受case reports吗?</span>, beContent=wf031 2020-01-26 00:00:00 发表: 请问接受case reports吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4995310914, createdName=14888d7am37暂无昵称, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]
    2020-06-29 1303935745

    审了一个半月+,还在awaiting reviewer scores

    3

    展开3条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=583868, encodeId=cb485838686f, content=请问接受case reports吗?<span class="quote">156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表:<br>您好,给编辑写信的邮箱能发下吗</span>, beContent=156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表: 您好,给编辑写信的邮箱能发下吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89b683177, createdName=wf031, createdTime=Sun Jan 26 00:00:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197030, encodeId=b97b119e030f8, content=偏重的研究方向:血液病分子生物学<br>经验分享:2022-02-16 su bmit 2022-02-18 编辑退回要求修改格式 2022-02-19 waiti n g ad m in..... 2022-02-23 U nder review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Thu Feb 24 22:21:33 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908358, encodeId=585c908358fb, content=请问审稿费多少呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a55434745, createdName=ms3000000661874644, createdTime=Tue Dec 15 22:52:17 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219448, encodeId=71f412194488c, content=投了一个月了还在awaiting reviewer assignment...服了太慢了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59915318778, createdName=148a3739m53暂无昵称, createdTime=Fri May 13 19:57:38 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198801, encodeId=ba7711988016e, content=请问Awaiting reviewer assignment会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Wed Mar 02 18:11:19 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552751, encodeId=ae96552e51c6, content=投出去快一礼拜了还是Awaiting Admin Processing,天天查状态,可能得等半个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3482046489, createdName=刘壮, createdTime=Mon Feb 19 16:08:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800420, encodeId=4604800420a4, content=审了一个半月+,还在awaiting reviewer scores, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6293088697, createdName=1303935745, createdTime=Mon Jun 29 21:40:07 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089551, encodeId=1d47108955100, content=评审和期刊编辑一般会询问什么问题?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089552, encodeId=145e1089552af, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586169, encodeId=6876586169dc, content=请问这个杂志接不接受case report呢?我也在找发case的杂志。<span class="quote">wf031 2020-01-26 00:00:00 发表:<br>请问接受case reports吗?</span>, beContent=wf031 2020-01-26 00:00:00 发表: 请问接受case reports吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4995310914, createdName=14888d7am37暂无昵称, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]
    2021-12-29 乌云背后的幸福线

    评审和期刊编辑一般会询问什么问题?

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=583868, encodeId=cb485838686f, content=请问接受case reports吗?<span class="quote">156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表:<br>您好,给编辑写信的邮箱能发下吗</span>, beContent=156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表: 您好,给编辑写信的邮箱能发下吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89b683177, createdName=wf031, createdTime=Sun Jan 26 00:00:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197030, encodeId=b97b119e030f8, content=偏重的研究方向:血液病分子生物学<br>经验分享:2022-02-16 su bmit 2022-02-18 编辑退回要求修改格式 2022-02-19 waiti n g ad m in..... 2022-02-23 U nder review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Thu Feb 24 22:21:33 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908358, encodeId=585c908358fb, content=请问审稿费多少呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a55434745, createdName=ms3000000661874644, createdTime=Tue Dec 15 22:52:17 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219448, encodeId=71f412194488c, content=投了一个月了还在awaiting reviewer assignment...服了太慢了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59915318778, createdName=148a3739m53暂无昵称, createdTime=Fri May 13 19:57:38 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198801, encodeId=ba7711988016e, content=请问Awaiting reviewer assignment会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Wed Mar 02 18:11:19 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552751, encodeId=ae96552e51c6, content=投出去快一礼拜了还是Awaiting Admin Processing,天天查状态,可能得等半个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3482046489, createdName=刘壮, createdTime=Mon Feb 19 16:08:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800420, encodeId=4604800420a4, content=审了一个半月+,还在awaiting reviewer scores, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6293088697, createdName=1303935745, createdTime=Mon Jun 29 21:40:07 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089551, encodeId=1d47108955100, content=评审和期刊编辑一般会询问什么问题?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089552, encodeId=145e1089552af, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586169, encodeId=6876586169dc, content=请问这个杂志接不接受case report呢?我也在找发case的杂志。<span class="quote">wf031 2020-01-26 00:00:00 发表:<br>请问接受case reports吗?</span>, beContent=wf031 2020-01-26 00:00:00 发表: 请问接受case reports吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4995310914, createdName=14888d7am37暂无昵称, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]
    2021-12-29 学医的彭于晏

    评审和期刊编辑要求我补实验,就一定要补么,不补行不行?

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=583868, encodeId=cb485838686f, content=请问接受case reports吗?<span class="quote">156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表:<br>您好,给编辑写信的邮箱能发下吗</span>, beContent=156YsRA2239(暂无昵称) 2019-11-30 00:00:00 发表: 您好,给编辑写信的邮箱能发下吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89b683177, createdName=wf031, createdTime=Sun Jan 26 00:00:00 CST 2020, time=2020-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197030, encodeId=b97b119e030f8, content=偏重的研究方向:血液病分子生物学<br>经验分享:2022-02-16 su bmit 2022-02-18 编辑退回要求修改格式 2022-02-19 waiti n g ad m in..... 2022-02-23 U nder review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Thu Feb 24 22:21:33 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908358, encodeId=585c908358fb, content=请问审稿费多少呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a55434745, createdName=ms3000000661874644, createdTime=Tue Dec 15 22:52:17 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219448, encodeId=71f412194488c, content=投了一个月了还在awaiting reviewer assignment...服了太慢了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59915318778, createdName=148a3739m53暂无昵称, createdTime=Fri May 13 19:57:38 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198801, encodeId=ba7711988016e, content=请问Awaiting reviewer assignment会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Wed Mar 02 18:11:19 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552751, encodeId=ae96552e51c6, content=投出去快一礼拜了还是Awaiting Admin Processing,天天查状态,可能得等半个月吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3482046489, createdName=刘壮, createdTime=Mon Feb 19 16:08:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800420, encodeId=4604800420a4, content=审了一个半月+,还在awaiting reviewer scores, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6293088697, createdName=1303935745, createdTime=Mon Jun 29 21:40:07 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089551, encodeId=1d47108955100, content=评审和期刊编辑一般会询问什么问题?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089552, encodeId=145e1089552af, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586169, encodeId=6876586169dc, content=请问这个杂志接不接受case report呢?我也在找发case的杂志。<span class="quote">wf031 2020-01-26 00:00:00 发表:<br>请问接受case reports吗?</span>, beContent=wf031 2020-01-26 00:00:00 发表: 请问接受case reports吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4995310914, createdName=14888d7am37暂无昵称, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]
    2020-03-08 14888d7am37暂无昵称

    请问这个杂志接不接受case report呢?我也在找发case的杂志。wf031 2020-01-26 00:00:00 发表:
    请问接受case reports吗?

    wf031 2020-01-26 00:00:00 发表: 请问接受case reports吗?

    2

    展开2条回复
共47条页码: 1/5页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分